drugset
drugset / Trial / NCT01439308

Intranasal SB-705498 in Non-allergic Rhinitis Patients

NCT01439308 ↗

Phase 2 Completed 40 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to look at the affect of SB-705498 on rhinitis symptoms, as induced by capsaicin challenge

Timeline

Start
2009-12
Primary completion
2010-04
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator SB-705498 Small molecule 12 mg Intranasal

Indications

rhinitis